Advanced Suture Retention Devices | Suturegard®
X

Dynamically Offload Tension
Increase Perfusion
DECREASE COMPLICATIONS

Contact Us

Our Mission

At SUTUREGARD Medical, our mission is to lead in the prevention and management of wound dehiscence through innovative wound closure technologies. We are dedicated to providing advanced solutions that minimize the risk of wound separation and promote optimal healing. SUTUREGARD's patented devices, including the HEMIGARD® ASRD and HEMIGARD® Interlock, are designed to reduce tension on wound edges, thereby significantly lowering the incidence of dehiscence. We aim to support surgeons in achieving secure, reliable closures, even in challenging high-tension areas, and to enhance patient outcomes by reducing complications associated with wound healing. By focusing on the prevention of dehiscence, we strive to improve recovery times, decrease healthcare costs, and elevate the standard of care in wound management. Our commitment to excellence drives us to continually innovate and refine our products, ensuring they meet the highest standards of safety and efficacy.

HEMIGARD® ASRD
Reduced Wound Dehiscence

The SUTUREGARD Adhesive Suture Retention Device (ASRD) is transforming surgical wound management, offering superior performance in high-tension wounds and expected post-surgical edema. The ASRD ensures optimal wound healing and minimizes complications, setting a new standard in surgical care. In three separate clinical studies, the use of HEMIGARD® ASRD was found to have 80% reduction of wound dehiscence versus standard layered closure.

Intra-op Benefits

  • Fast, easy, and low risk application
  • Tension offloading ensures precise skin edge approximation
  • Decreases the necessity for delayed closures or skin flaps/grafts

Post-op Benefits

  • Disperses tension on the wound, safeguarding primary closure
  • Preserves blood flow to skin edges for adequate oxygen and nutrient supply
  • Alleviates stress on the wound closure due to swelling
  • Reduces blistering by adapting to skin movement and tension

HEMIGARD® ASRD
Most Common Procedures

Foot & Ankle Surgery

Surgeon Testimonials

The HEMIGARD® is revolutionizing difficult incisional closures on any extremity.

- Mark Myserson, MD, Past President of the AOFAS

For complex wound closures like amputations or rotational flaps, for me HEMIGARD® is mandatory. Combining barbed suture running sub-cuticular closure augmented with HEMIGARD® to reduce the pressure along the incision line, I have been able to prevent lower leg dehiscence in most of my cases.

- Patrick DeHeer, DPM

I make sure the HEMIGARD is in my OR. With it, I have prevented dehiscence of amputation sites, and I use it on high-risk incisions and incisions spanning joints as "suspenders" on my suturing.

- Danielle Butto, DPM

The HEMIGARD® is an "insurance plan" for my incisions. I can allow earlier ROM and weightbearing while removing stitches/staples in 2-3 weeks and the HEMIGARD in 4-5 weeks.

- Arun Karwal, DPM

SUTUREGARD® Medical among
MedTech's Top Innovators

"MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization’s flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe."

Read More

Upcoming Events

Toes in the Sand Meeting

Friday, August 16 to Sunday, August 18

Eau Palm Beach Resort & Spa

AOFAS Annual Meeting

September 11-14, 2024

Vancouver Convention Centre

Vancouver, British Columbia, Canada

Prevent and Manage Wound Dehiscence.

Making wound closure easier for surgeons and better for patients.

Contact Us